Superoxide dismutase isoenzyme activities in plasma and tissues of Iraqi patients with breast cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 6, 2012, Pages 2571-2576

  Hasan, Hathama Razooki ^a   Mathkor, Thikra Hasan ^a   Al Habal, Mohammed Hasan ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Breast cancer; CuZn SOD; EC SOD; Lipid peroxidation; Mn SOD; total SOD

Indexed keywords

EID: 84874061773     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.6.2571     Document Type: Article

References (70)

1. Akbulut H, Akbulut KG, Icli, et al(2003). Daily variation of plasma malondialdehyde levels in patients with early breast cancer. Cancer Detect Prev, 27, 122-6.
2. Alagol E, Erdem E, Sancak B, et al(1999). Nitric oxide biosynthesis and malondialdeyhde levels in advanced breast cancer. Aust NZJ Surg, 69, 647-0.
3. Alwan NAS (2010). Breast cancer, demographic characteristics and clinico-pathological presentation of patients in Iraq. EMHJ, 16, 1159-4.
4. Ames BN (1983). Dietary carcinogens and anticarcinogenes oxygen radicals and degenerative diseases. Science, 221, 1256-4.
5. Arid KM, Allensworth JL, Batinic-Haberle I, et al(2012). ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cells. Breast Cancer Res Treat, 132, 109-9.
6. Brown NS, Bicknell R (2001). Hypoxia and oxidative stress in breast cancer Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res, 3, 323-7.
7. Budroe JD, Umemura T, Angeloff K, et al(1992). Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferators ciprofibrate in C57BL/6N and BALB/C mice. Toxicol Appl Pharmacol, 113, 192-8.
8. Buettner GR (2011). Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem, 11, 341-6.
9. Cerutti P, Larsson R, Krupitza G, et al(1989). Pathophysiological mechanisms of active oxygen. Mutat Res, 214, 81-8.
10. Cerutti PA (1985). Prooxidant states and tumor promotion. Science, 227, 375-1.
11. Conrade E, (1998)"Heparin-Binding Protein"Academic Press, USA 351-6
12. Dean RT, Shanlin FU, Stoker R, et al(1997). Biochemical & pathology of radical medicated protein oxide. Biochem J, 324, 1-18.
13. Demple B, (1991). Regulation of bacterial oxidative stress genes. Annu Rev Genet, 25, 315-7.
14. Dionisi D, Galeotti T, Terranove T, et al(1975). Superoxide radicals and hydrogen peroxide formation in mitochondria from normal and neoplastic tissue. Biochim Biophys Acta, 403, 292-0.
15. Durak I, Isik AC, Canbolat O, et al(1993). Adenosine deaminase,'5-nucleolidase,xanthine Oxidase, Superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissue. Free Radic Biol Med, 15, 681-4.
16. Durak I,Perk H,Kavutcu M, et al(1994). Adenosine deaminase,'5- nucleolidase, xanthine Oxidase, Superoxide dismutase, and catalase activities in cancerous and noncancerous human bladder tissues. Free Radic Biol Med, 16, 825-1.
17. Enghild JJ, Thgersen IB, Oury TD, et al(1999). The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J Biol Chem, 274, 14818-2.
18. Gönenç A, Erten D, Aslan S, et al(2006). Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int, 30, 376-0.
19. Guo G, Yan-Sanders Y, D Lyn-Cook B, et al(2003). Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol, 23, 2362-8.
20. Gutteridge JMC (1995). Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem, 41,1819-8.
21. 2. J Bio Chem, 217, 4138-2.
22. Halliwell B, (1982). Production of superoxide hydrogen peroxide and hydroxyl radicals by phagocytic cells, a cause of chronic inflammatory disease. Cell Biol Int Rep, 6, 529-2.
23. Halliwell B, Gutteridge JM (1985). The importance of free radicals & catalytic metals ions in human diseases. Mol Aspects Med, 8, 89-3.
24. rd, PP129 Oxford university Press New York.
25. Hasan HR, Numan AW (2009). Extracellular superoxide dismutase changes in patients with different brain tumors. Iraqi J Sci, 50,1-7.
26. Hassan HM, Fridovich I (1981). Chemistry & biochemistry of Superoxide dismutase. Eur J Rheumtol inflamm, 4,160-2.
27. Hietanen E, Punnonen K, Punnonen R, et al(1989). Fatty acids composition and lipid peroxiddation in human breast cancer and lipoma tissue. Carcinogenesis, 7, 1965-9.
28. Hirayama A, Nagase S, Gotoh M, et al(2000). Hemodialysis does not influence the peroxidative state already present in uremia. Nephron, 86, 436-0.
29. Holley AK, Dhar SK, Xu Y, et al(2012). Manganese superoxide dismutase: beyond life and death. Amino Acids, 42, 139-8.
30. Iwase K, Kato K, Ohtani S, et al(1997). The relation between Superoxide dismutase in cancer tissue and clinic-pathological features in breast cancer. Breast Cancer, 4, 155-0.
31. Karlsson K, Marklund SL (1987). Heparin-induced release of Extracellular superoxide dismutase to human blood plasma. Biochem J, 242, 55-9.
32. Karlsson K, Marklund SL (1988). Extracellular superoxide dismutase in the vascular system of mammals. Biochem J, 255, 223-8.
33. Lin Y, Kikuchi S, Obata Y, et al(2002). Serum copper/zinc superoxide dismutase (Cu/Zn SOD) and gastric cancer risk, a case-control study. Jpn J Cancer Res, 93,1071-5.
34. Lowry OH, Rosebrough NJ, Farr AL, et al(1951). Protein measurement with Folin phenol reagent. J Biol Chem, 1193, 265-5.
35. Margaret Ay Ly, Syahruddin E, Wanandi SI (2011). Low activity of Mn-SOD in blood of lung cancer patients with smoking history, relationship to oxidative stress. Asian Pac J Cancer Prev, 12, 3049-3.
36. Marklund SL, Holme E, Hellner L (1982). Superoxide dismutase in extracellular fluids. Clin Chim Acta, 126, 41-1.
37. Marklund, SL (1984). Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J, 222, 649-5.
38. Mitrunen K, Sillanpaa P, Kataja V, et al(2001). Association between manganese superoxide dismutase (Mn-SOD) gene polymorphism and breast cancer risk. Carcinogenesis, 22, 827-9.
39. Mobley JA and Brueggemeier RW (2004). Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis, 25, 3-9.
40. Monteiro HP, Stern A (1996). Redox modulation of tyrosine phosphorylation - dependent signal transduction pathways. Free Radic Biol Med, 21, 323-3.
41. Moraes EC, Keyse SM, Tyrrell MR (1990). Mutagenesis by hydrogen peroxide treatment of mammalian cells, a molecular analysis. Carcinogenesis, 11, 283-3.
42. Nakada T, Koike H, Katayama T (1987). Low level of Superoxide dismutase activity in pheochromocytoma. J Urol, 138, 9-13.
43. Nakamura Y, Gindhart TD, Winterstein D, et al(1988). Early Superoxide dismutase-sensitive event promotes neoplastic transformation in mouse epidermal JB6 cells. Carcinogenesis, 9, 203-7.
44. Nakamura Y, Ohtaki S, Makino R, et al(1988). Superoxide anion is the initial product in the hydrogen peroxide formation catalyzed by NADPH oxydase in porcine thyroid plasma membrane. J Biol Chem, 264, 4759-1.
45. Oberley LW(2005). Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother, 59, 143-8.
46. Oberley LW, Bize IB, Sahu SK, et al(1978). Superoxide dismutase activity of normal murine liver, regenerating liver, and H6 hepatoma. J Natl Cancer Inst, 61, 375-9.
47. Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-8.
48. Oyanagui Y (1984). Re-evaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem, 142, 290-6.
49. Ozturk HS, Karaayvaz M, Kacmaz M,et al(1998). Activities of the enzymes participating in purine and free-radical metabolism in cancerous human colorectal tissues. Cancer Biochem Biophys, 16,157-8.
50. Perchellet JP, Perchllet EM (1989). Antioxidants and multistage carcinogenesis in mouse skin. Free Radi Biol Med, 7, 377-8.
51. Pham TM, Fujino Y, Nakachi K, et al(2009). Relationship between serum levels of superoxide dismutase activity and subsequent risk of cancer mortality, Findings from a nested case-control study within the Japan Collaborative Cohort Study. Asian Pac J Cancer Prev, 10, 69-3.
52. Punnonen K, Ahotupa M, Asaishi K, et al(1994). Antioxidant enzyme activities and oxidative stress in human breast cancer. J Cancer Res Clin Oncol,120, 374-7.
53. Ridnour LA, Oberley TD, Oberley LW (2004). Tumor suppressive effects of MnSOD overexpression may involve imbalance in peroxide generation versus peroxide removal. Antioxid Redox Signal, 6, 501-12.
54. Rizwan A, Anil KT, Payal T, et al(2008). Oxidative stress and antioxidant status in patients with chronic myeloid leukemia. Indian J Clin Biochem, 23, 328-3.
55. Robbins D, Zhao Y (2011). The role of manganese superoxide dismutase in skin cancer. Enzyme Res, 2011, 1-7.
56. Saez G, Thornalley PJ, Hill HA, et al(1982). The production of radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes. Biochem Biophys Act, 719, 24-1.
57. Saintot M, Astre C, Pujol H, et al(1996). Tumor progression and oxidant-anti oxidant status. Carcinogenesis, 17, 1267-1.
58. Sandstrom J, Karlsson K, Edlund T, et al(1993). Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J, 294, 853-7.
59. Shay JW, Werbin H (1989). Are mitochondrial DNA mutations involved in the carcinogenic procces? Mutatres, 186,149-0.
60. 2- resistant fibroblasts. ABB, 292, 221-7.
61. 2- resistant Chinese hamster fibroblast cell lines. ABB, 279, 249-0.
62. Srivastava S, Natu SM, Gupta A, et al(2009). Lipid peroxidation and antioxidants in different stages of cervical cancer: Prognostic significance. Indian J Cancer, 46, 297-2.
63. 2-mediated injury. Am J Physiol, 262, 748-6.
64. Sun Y, Oberley LW (1996). Redox regulation of transcriptional activators. Free Radic Biol Med, 21, 335-8.
65. Wang M, Dhingra K, Hittelman WN, et al(1996). Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biomarkers Prev, 5, 705-0.
66. Wiseman H, Halliwell B (1996). Damage to DNA by reactive oxygen and nitrogen species, role in inflammatory disease and progression to cancer. Biochem J, 313, 17-29.
67. Xing G, Romanyukha A, Bunger R (2008). Reactive oxygen species (ROS) in human breast cancer cell lines differing in malignancy, an electron paramagnetic resonance (EPR) Study. FASEB J, 22, 79410.
68. Yamanaka NY, Deamer D (1974). Superoxide dismutase activity in W1-38 cell cultures Effects of age, trypsinization, and SV- 40 transformation. Physiol Chem Phys, 6, 95-106.
69. Zaridze DG, Chevchenko VE, Levtshuk AA, et al(1990). Fatty acid composition of phospholipids in erythrocyte membranes and risk of breast cancer. Int J Cancer, 45, 807-0.
70. Zhang Y, Smith BJ, Oberley LW (2006). Enzymatic activity is necessary for the tumor-suppressive effects of MnSOD. Antioxid Redox Signal, 8, 1283-3.